1. Introduction {#sec1-molecules-21-00299}
===============

Uranium is introduced into the body by ingestion, inhalation, or through wounds. The risk of uranium contamination has considerably magnified because of the extensive use of uranium as nuclear fuel in fission reactors and as weapon-grade nuclear material. The hexavalent uranyl ion \[UO~2~^2+^, U(VI)\] is the most stable form *in vivo* \[[@B1-molecules-21-00299]\] and is complexed in the blood by chelating agents, such as proteins or carbonates. Meanwhile, tissues, especially the kidney and bones, accumulate uranium for months to years, which will induce cancer and chemical intoxication \[[@B2-molecules-21-00299],[@B3-molecules-21-00299],[@B4-molecules-21-00299]\]. Thus, uranium should be eliminated from the body by administration of nontoxic chelating agents that can form stable complexes with the uranyl ion.

Among the different chelators, 3-Hydroxy-4-pyridinones (3,4-HOPO) have emerged as one of the hotspots in studies that focus on heavy metal chelators because of their special bidentate structure, highly selective chelating capacity, and significant physiological activities \[[@B5-molecules-21-00299],[@B6-molecules-21-00299],[@B7-molecules-21-00299],[@B8-molecules-21-00299],[@B9-molecules-21-00299],[@B10-molecules-21-00299],[@B11-molecules-21-00299],[@B12-molecules-21-00299]\]. To date, three kinds of 3,4-HOPO derivatives are available, namely bidentate hydroxypyridinones \[[@B5-molecules-21-00299],[@B6-molecules-21-00299]\], tetradentate hydroxypyridinones \[[@B7-molecules-21-00299],[@B8-molecules-21-00299],[@B9-molecules-21-00299]\], and hexadentate hydroxypyridinones \[[@B10-molecules-21-00299],[@B11-molecules-21-00299]\]. The ideal design for chelators is to synthesize the hydroxypyridinones, which have excellent chelating efficacy and high selectivity of interaction, with special biological receptors in one molecular unity. The chelating capacity of bidentate hydroxypyridinones is usually inferior to that of hexadentate desferrioxamine \[[@B13-molecules-21-00299],[@B14-molecules-21-00299]\]. Hexadentate hydroxypyridinones have a higher chelating ability than hexadentate desferrioxamine, but the poor absorption caused by their high molecular weight limits their application \[[@B15-molecules-21-00299]\]. Thus, tetradentate hydroxypyridinones have been one of most extensively investigated compounds among heavy metal chelators \[[@B16-molecules-21-00299]\]. Recent studies have reported that the tetradentate hydroxypyridinones exhibit better assays *in vivo* such as high chelating efficacy for Fe and Ga as well as excellent hydrophilic character \[[@B17-molecules-21-00299],[@B18-molecules-21-00299],[@B19-molecules-21-00299],[@B20-molecules-21-00299]\]. However, few studies have examined the hydroxypyridinone chelating uranyl ions. In this paper, a series of new tetradentate hydroxypyridinone chelators is reported, and the binding affinities towards a uranyl cation (UO~2~^2+^) were examined with UV spectrophotometry.

2. Results and Discussion {#sec2-molecules-21-00299}
=========================

2.1. Synthesis {#sec2dot1-molecules-21-00299}
--------------

The synthesis of tetradentate hydroxypyridinones **4a**--**e** is shown in [Scheme 1](#molecules-21-00299-f003){ref-type="scheme"}. Starting from the commercially available 3-hydroxy-2-methyl-4-pyrone (maltol), the hydroxyl was protected with benzyl bromide and proceeded in excellent yield (93%) to produce 3-benzyloxy-2-methyl-4-pyrone **1**. Then 3-Benzyloxy-2-methyl-4-pyrone **1** was directly condensed with diamines or ammonia alcohols to provide benzyloxy-pyridone derivatives **2a**--**e** in 75%--89% yields. This method was similar to that described by Santos \[[@B18-molecules-21-00299]\] but with minor modifications. In this study, for benzyloxy-pyridone **2a**, compared with the method of Santos, the molar ratio of amines with pyrone **1** was increased from 1:1 to 3:1, and the corresponding yield of **2a** evidently increased from 40% to 87%. The structures of benzyloxy-pyridones **2a**--**e** contained a reactive hydroxyl or amino group, which could easily react with malonyl dichloride to yield the corresponding condensed products **3a**--**e**. The malonyl dichloride is extremely active, so the reaction should be conducted in an ice bath and anhydrous conditions. Removal of benzyl from the oxygen of **3a**--**e** catalytic hydrogenation conditions (14.5 psi H~2~, 10% Pd/C as catalyst) proceeded smoothly with good yield (71%--90%) to produce tetradentate hydroxypyridinones **4a**--**e**.

2.2. Characterization {#sec2dot2-molecules-21-00299}
---------------------

All products were purified and characterized by FT-IR, NMR, UV-vis and MS, and all characterizations were in accordance with the structures of the products.

The ^1^H-NMR spectra of compounds **2**--**4a** are shown in [Figure 1](#molecules-21-00299-f001){ref-type="fig"}. Compared with **2a**, the signal of NHC*H~2~*CH~2~- in **3a** shifted to the low chemical field (from 2.75 to 3.31) because of the electrophilic effect of the --CONH, and the singlet of the --COC*H*~2~CO-- in **3a** appeared at δ = 3.20 ppm. Compound **4a** was obtained after the hydroxyls of **3a** were deprotected. The peaks at 7.34 ppm of the benzene ring and 5.07 ppm of the methylene disappeared when the benzyl group was removed, and the signal of the *CH*~3~-Pys shifted from 2.16 ppm to 2.42 ppm.

The ^1^H-NMR spectra of **2b**--**e**, **3b**--**e**, and **4b**--**e** have similar results. The ^1^H-NMR spectra of **4b** and 4**c** exhibit two doublets at 7.6 ppm--7.7 ppm and 6.45 ppm--6.55 ppm with *J*~AB~ = 7.5 Hz for the two nonequivalent protons in the pyridine ring. Compared with **4d** and **4e**, the signals of the pyridine ring protons appeared in the higher field because the oxygen atom is more electronegative than the nitrogen atom. The signals of the two nonequivalent protons in the pyridine rings of **4d** and 4**e** appeared at 8.30 ppm--8.33 ppm (d, *J* = 7.2 Hz, 1H) and 7.23 ppm--7.25 ppm (d, *J* = 7.2 Hz, 1H), respectively. Additionally, the signals of --COC*H~2~*CO-- in **4d** and **4e** appeared in a lower field than in **4b** and **4c** under the same condition. The singlet of --COC*H*~2~CO-- in **4b** and **4c** appeared at 3.0 ppm--3.1 ppm, whereas that of **4d** and **4e** appeared at 3.6 ppm--3.8 ppm, respectively.

2.3. Complexation {#sec2dot3-molecules-21-00299}
-----------------

Although present metal-complexation studies are focused on a set of three-charged hard metal ions \[[@B21-molecules-21-00299],[@B22-molecules-21-00299]\] (e.g., Fe, Al, and Ga), the current study on decorporation \[[@B23-molecules-21-00299]\] for UO~2~^2+^ is based on the extreme damage to the environment caused by uranyl cations (UO~2~^2+^) in biological systems. In this paper, the complexation behavior of tetradentate hydroxypyridinones **4a**--**e** and the uranyl cation was evaluated by the spectrophotometric method \[[@B24-molecules-21-00299],[@B25-molecules-21-00299]\].

We defined:

M = UO~2~^2+^; L = ligands **4a**--**e**

C = \[M\] + \[L\]; x = \[M\]/C

The coordination numbers (M:L) and the corresponding complex stability constants of the five tetradentate hydroxypyridinones **4a**--**e** toward UO~2~^2+^ at pH 7.4 were measured with the method of equivalent molarity. The UV-vis spectra of the various metal-to-ligand molar ratios for the UO~2~^2+^-ligand **4a**--**e** system at pH 7.4 are shown in [Figure 2](#molecules-21-00299-f002){ref-type="fig"}. UO~2~^2+^ has an absorption peak at 229 nm, the peak at 278 nm was a characteristic absorption of ligand **4a**, and a new peak at 303 nm appeared, which indicated that a new peak was the characteristic of the UO~2~^2+^-ligand **4a** complexation ([Figure 2](#molecules-21-00299-f002){ref-type="fig"}a). To construct the Job plot, the absorbance values were normalized according to the complex absorbance, and the experimental absorbance values of the UO~2~^2+^-ligand **4a** complexation at pH 7.4 are plotted against the mole fraction ([Figure 2](#molecules-21-00299-f002){ref-type="fig"}b). The result shows that the complex stoichiometry for the complexation of UO~2~^2+^-ligand **4a** at pH 7.4 is *M*/*L* = 2:3 (x = 0.4). This value indicates that the three ligand molecules could bridge two bis-chelated UO~2~^2+^ centers under the effect of polar solvent molecules to complete their coordination sphere at pH 7.4.

Then ligands **4a**--**e** complex with the uranyl, and the formation constants (log K) for the ligands could be calculated as follows: **2 M+3 L=M~2~L~3~**Initial concentration:xC(1 − x)C0Equilibrium concentration:\[M\]~E~\[L\]~E~\[M~2~L~3~\]~E~Complete reaction:00\[M~2~L~3~\]~C~

Based on the Lambert-Beer law: $$\left. \frac{A_{E}}{\left\lbrack {M_{2}L_{3}} \right\rbrack_{E}} = \frac{A_{C}}{\left\lbrack {M_{2}L_{3}} \right\rbrack_{C}}\Rightarrow\left\lbrack {M_{2}L_{3}} \right\rbrack_{E} = \frac{A_{E}\left\lbrack {M_{2}L_{3}} \right\rbrack_{C}}{A_{C}} \right.$$ $$\log K = \frac{{\lbrack M_{2}L_{3}\rbrack}_{E}}{{\lbrack M\rbrack}_{E}^{2}{\lbrack L\rbrack}_{E}^{3}} = \log\frac{{\lbrack M_{2}L_{3}\rbrack}_{E}}{\left\{ xC - 2{\lbrack M_{2}L_{3}\rbrack}_{E} \right\}^{2}\left\{ (1 - x)C - 3{\lbrack M_{2}L_{3}\rbrack}_{E} \right\}^{3}}$$

The complex stability constant of **4a** and UO~2~^2+^ at pH 7.4 was calculated by Equation (1), and the corresponding logK~cond~U-L **4a** at 7.4 pH levels was 21.7. The corresponding complex stability constants of other ligands were also calculated by Equation (1), and the results are shown in [Table 1](#molecules-21-00299-t001){ref-type="table"}.

Although the structures of Ligands **4a**--**e** are similar, some consistent differences are apparent. The change of the linker length has a great influence on the their U(VI) chelation efficiency \[[@B26-molecules-21-00299],[@B27-molecules-21-00299],[@B28-molecules-21-00299]\]. As the length of the linker increases, the angle formed between the uranium and two phenolic oxygen donors also becomes greater, and it leads to an increase of the strain in this complex. \[[@B29-molecules-21-00299]\] As a result of the strain imposed by the linker, that two carbon atoms may be considered the optimal length is consistent with the high efficacy of ligands **4b** and **4e** for [in vivo](mailto:in vivo) uranyl chelation. Ligands **4b** and **4e** exhibit the highest K~cond~ at pH 7.4, and the corresponding logK~cond~ are 22.7 and 22.2. The modest reduction of body uranium in animals by the injection of bidentate Tiron (4,5-dihydroxy-1,3-benzenedisulfonic acid, disodium salt) and its U(VI)-catechol complex (log KML ) is 15.9 \[[@B29-molecules-21-00299],[@B30-molecules-21-00299],[@B31-molecules-21-00299]\], which suggests the U(VI)-Ligands **4b** complex and U(VI)-Ligands **4e** complex Ligands 4b and 4e exhibit higher stability than the U(VI)-Tiron complex. Thus, Ligands **4b** and **4e** are most suitable for further studies.

3. Materials and Methods {#sec3-molecules-21-00299}
========================

3.1. General {#sec3dot1-molecules-21-00299}
------------

The organic reagents used were pure commercial products from Aladdin. The solvents were purchased from Chengdu Kelong Chemical Reagents Co. (Sichuan, China). Anhydrous CH~2~Cl~2~ was distilled prior to use. The 300--400 mesh silica gel was purchased from Qingdao Hailang. The ^1^H-NMR, ^13^C-NMR spectra were recorded on Bruker Avance 300, Avance 400, or Avance 600 spectrometer (Carlsruhe, Germany). The FTIR spectra were obtained from Nicolet 380 FTIR spectrophotometer (Thermo Fisher Nicolet, Madison, WI, USA) with a resolution of 4 cm^−1^ from 400 cm^−1^ to 4000 cm^−1^. UV-vis spectrophotometer (Thermo Scientific Evolution 201, Waltham, MA, USA) used had a double-beam light source from 190 nm to 1100 nm. Mass spectral analysis was conducted using Varian 1200 LC/MS (Palo Alto, CA, USA).

3.2. Synthesis {#sec3dot2-molecules-21-00299}
--------------

*Synthesis of 3-benzyloxy-2-methyl-4-pyrone* (**1**). To a solution of 10.00 g 3-hydroxy-2-methyl-4-pyrone (79 mmol) containing the equivalent amount of NaOH (3.16 g, 79 mmol) in 100 mL methanol, 13 mL benzyl bromide (90 mmol) was dropwise added and then stirred for 6 h under reflux temperature. After cooling, the reaction mixture was evaporated under vacuum, and the residual oil was resolved in 50 mL dichloromethane and washed with 5% NaOH aqueous solution (5 × 30 mL) and water (3 × 50 mL). The organic solution was evaporated to dryness to obtain the pure product as pale oil (15.7 g, 93%). UV-vis (CH~3~OH): λ~max~ = 219, 260 nm. FT-IR (KBr): ν = 3065, 3031, 2958, 2877, 1644, 1575, 1496, 1455, 1428, 1253, 1186, 1079, 973, 915, 832, 751, 703 cm^−1^. ^1^H NMR (300 MHz, CDCl~3~): δ =7.57 (d, *J* = 6.0 Hz, 1H), 7.25--7.40 (m, 5H), 6.33 (d, *J* = 6.0 Hz, 1H), 5.13 (s, 2H, *CH*~2~Ph), 2.06 (s, 3H, *CH*~3~) ppm. MS (APCI, CH~3~OH) *m*/*z* (%) = 217 (100) \[M + H\]^+^. C~13~H~12~O~3~ (216.3): calcd. C 72.22, H 5.56; found: C 72.43, H 5.47.

*Synthesis of (3′-aminopropyl)-3-benzyloxy-2-methyl-4-pyridinone* (**2a**). First 3 g 3-Benzyoxy-2-methyl-4-pyrone (13.9 mmol), 3.5 mL 1,3-diaminopropane (42.1 mmol) and 0.5 g NaOH were added in a EtOH--water mixture (20/15) mL, and then stirred at 75 °C for 3 h. After cooling, 2 M HCl was added until the pH = 1, and the reaction mixture was evaporated under vacuum. The residue was washed with acetone and dissolved in 20 mL water. Then the aqueous was basified with 10 M NaOH until pH = 12, and extracted with dichloromethane (5 × 30 mL). The organic solution was evaporated to dryness to obtain the faint yellow oil (3.5 g, 87%). UV-vis (CH~3~OH): λ~max~ = 213, 277 nm. FT-IR (KBr ): ν = 3432 (N-H), 3063, 3030 (C-H, Ar), 2492, 2872 (C-H), 1622(C=O), 1550, 1250, 838, 752, 703 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ =7.73 (d, *J* = 6.0 Hz, 1H), 7.30--7.42 (m, 5H), 6.47 (d, *J* = 7.4 Hz, 1H), 5.08 (s, 2H, *CH*~2~Ph), 4.03 (t, *J* = 7.5 Hz, 2H), 2.75 (t, *J* = 7.2 Hz, 2H, NH~2~*CH*~2~CH~2~), 2.19 (s, 3H, CH~3~), 1.87 (m, 2H, CH~2~*CH*~2~CH~2~) ppm. MS (APCI) *m*/*z* (%) = 273.0 (100) \[M + H\]^+^. C~16~H~20~O~2~N~2~ (272.1): calcd. C 70.59, H 7.35, N 10.29; found: C 70.61, H 7.37, N 10.24.

*Synthesis of N,N′-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)propyl)malonamide* (**3a**). First 0.4 g (3*′*-aminopropyl)-3-benzyloxy-2-methyl-4-pyridinone (1.5 mmol) and 2 mL triethylamine were added in 50 mL dichloromethane, then mixture was stirred at 0 °C under N~2~. Then 75 μL malonyl dichloride was diluted with 20 mL dichloromethane and then dropwise added slowly and consecutively keeping the temperature at 0 °C for 8 h. The mixture was purified by chromatography on a silica-gel column with the methanol: chloroform = 1:6 as eluent, the pure product was white powder (0.29 g, 64%). UV-vis (CH~3~OH): λ~max~ = 213, 279 nm. FT-IR (KBr): ν = 3226 (N-H), 3063 (C-H, Ar), 2935, 2879, 1654, 1624, 1559, 1518, 1249, 1249, 1218, 1160, 1036, 975, 833, 750, 703 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ = 7.72 (d, *J* = 7.2 Hz, 2H), 7.29--7.41 (m, 10H), 6.48 (d, *J* = 7.2 Hz, 2H), 5.07 (s, 4H, C*H*~2~Ph), 4.00 (t, *J* = 7.5 Hz, 4H, NHCH~2~CH~2~C*H*~2~), 3.31 (t, *J* = 6.0 Hz, 4H, NHC*H*~2~CH~2~CH~2~), 3.20 (s, 2H, CO*CH*~2~CO), 2.16 (s, 6H, C*H~3~*), 1.87 (m, 4H, CH~2~C*H*~2~CH~2~) ppm. MS (APCI) *m*/*z* (%) = 613 (100) \[M + H\]^+^. C~35~H~40~O~6~N~4~ (612): calcd. C 68.63, H 6.54, N 9.15; found: C 68.42, H 6.83, N 9.51.

*Synthesis of N,N′-bis(4-(3-hydroxy-2-methyl-4-pyridinone)propyl)malonamide* (**4a**). First 40 mg 10% Pd/C was added in a solution of *N,N′*-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)propyl)malonamide (0.2 g, 3.7 mmol) in methanol (50 mL), then the mixture was stirred under H~2~ (1 atm) for 4 h at room temperature. After filtration, the solvent was evaporated under reduced pressure and the product was obtained as the white powder (0.13 g, 89%). UV-vis (CH~3~OH): λ~max~ = 279 nm. FT-IR (KBr): ν = 3069, 2930, 1656 (C=OCH~2~), 1627 (PyC=O), 1561, 1509, 1251 (C=ONH~2~), 1035, 832 cm^−1^. ^1^H-NMR (600 MHz, DMSO-*d*~6~): δ =7.64 (d, *J* = 7.2 Hz, 2H), 6.48 (d, *J* = 7.2 Hz, 2H), 4.10 (t, *J* = 7.5 Hz, 4H, NHCH~2~CH~2~C*H*~2~), 3.31 (t, *J* = 6.0 Hz, 4H, NHC*H*~2~CH~2~CH~2~), 3.21 (s, 2H, COC*H*~2~CO), 2.42 (s, 6H, C*H*~3~), 1.96 (m, 4H, CH~2~C*H*~2~CH~2~) ppm. ^13^C-NMR (150 MHz, DMSO-*d*~6~): δ = 169.19, 168.48, 145.95, 137.55, 131.33, 128.01, 51.43, 46.52, 35.98, 30.06, 10.46 ppm. MS (APCI) *m*/*z* (%)= 217 (100) \[M + 2H\]^+^. C~21~H~28~O~6~N~4~ (432): calcd. C 58.33, H 6.48, N 12.96; found: C 57.97, H 6.51, N 12.85.

*Synthesis of (3′-aminoethyl)-3-benzyloxy-2-methyl-4-pyridinone* (**2b**). First 3 g 3-benzyoxy-2-methyl-4-pyrone (13.9 mmol) and 3.3 mL ethanediamine (49.3 mmol) were added in a EtOH--water mixture (20/15) mL, then 0.5 g NaOH was added and stirred at 70 °C for 4 h. After cooling, 2 M HCl was added until the pH = 1 and the solvent was evaporated. The residue was washed with acetone and dissolved in 20 mL water. The obtained solution was basified with 10 M NaOH until pH ≈ 12 and extracted with dichloromethane (5 × 30 mL). The organic phase was evaporated and obtained the flavescent oil (2.84 g, 74%). UV-vis (CH~3~OH): λ~max~ = 213, 277 nm. FT-IR (KBr): ν = 3433, 1591, 1490, 1384, 1332, 1103, 824, 592 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ = 7.67 (d, *J* = 7.5 Hz, 1H), 7.30--7.42 (m, 5H), 6.46 (d, *J* = 7.5 Hz, 1H), 5.07 (s, 2H, C*H*~2~Ph), 3.96 (t, *J* = 7.5 Hz, 2H, NH~2~C*H~2~*CH~2~), 2.84 (t, *J* = 7.2 Hz, 2H, NH~2~CH~2~C*H*~2~), 2.17 (s, 3H, C*H*~3~) ppm. MS(APCI) *m*/*z* (%) = 259 (100) \[M + H\]^+^. C~15~H~18~O~2~N~2~ (258.1): calcd. C 69.77, H 6.98, N 10.85; found: C 70.23, H 7.17, N 10.49.

*Synthesis of* *N,N′-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)ethyl)malonamide* (**3b**). First 0.4 g (3′-aminoethyl)-3-benzyloxy-2-methyl-4-pyridinone (1.5 mmol) and 2 mL triethylamine were added in 50 mL dichloromethane, then mixture was stirred at 0 °C under N~2~. Then 75 μL malonyl dichloride was diluted with 20 mL dichloromethane and then dropwise added slowly and consecutively keeping the temperature at 0 °C for 8 h. The mixture was purified by chromatography on a silica-gel column with the methanol: chloroform = 1:6 as eluent, and the pure product was white powder (0.26 g, 58%). UV-vis (CH~3~OH) λ~max~ = 213, 279 nm. FT-IR (KBr): ν = 2987, 1961, 1676, 1623, 1548, 1507, 1395, 1252, 1164, 1034, 880, 835, 752, 703, 613 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ = 7.62 (d, *J* = 7.5 Hz, 2H), 7.28--7.44 (m, 10H), 6.44 (d, *J* = 7.5 Hz, 2H), 5.04 (s, 4H, *CH*~2~Ph), 4.07 (t, *J* = 6.0 Hz, 4H, NHCH~2~C*H*~2~), 3.45 (t, *J* = 6.0 Hz, 4H, NHC*H*~2~CH~2~), 3.08 (s, 2H, COC*H*~2~CO), 2.16 (s, 6H, CH~3~). MS (APCI) *m*/*z* (%) = 585 (100) \[M + H\]^+^. C~33~H~36~N~6~O~4~ (584): calcd. C 67.81, H 6.16, N 9.56; found: C 67.55, H 5.87, N 9.38.

*Synthesis of* *N,N′-bis(4-(3-hydroxy-2-methyl-4-pyridinone)ethyl)malonamide* (**4b**). First 40 mg 10% Pd/C was added in a solution of *N,N′*-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)ethyl)malonamide **3b** (0.2 g, 3.7 mmol) in methanol (50 mL), then the mixture was stirred under H~2~ (1 atm) for 4 h at room temperature. After filtration, the solvent was evaporated under reduced pressure and the product was obtained as the white powder (0.12 g, 83%). UV-vis (CH~3~OH): λ~max~ = 279 nm. FT-IR (KBr): ν = 3429, 3069, 2093, 1654, 1627, 1561, 1509, 1353, 1251, 1035, 831 cm^−1^. ^1^H-NMR (600 MHz, CD~3~OD): δ = 7.62 (d, *J* = 7.5 Hz, 2H), 6.46 (d, *J* = 7.5 Hz, 2H), 4.07 (t, *J* = 6.0 Hz, 4H, NHCH~2~C*H*~2~), 3.45 (t, *J* = 6.0 Hz, 4H, NHC*H*~2~CH~2~), 3.08 (2H, s, COC*H*~2~CO), 2.16(6H, s, C*H~3~*) ppm. MS (APCI) *m*/*z* (%) = 405 (100) \[M + H\]^+^. C~19~H~24~O~6~N~4~ (404): calcd. C 56.44, H 5.94, N 13.86; found: C 56.38, H 6.25, N 13.74.

*Synthesis of* *N-(4-aminophenyl)-3-benzyloxy-2-methyl-4-pyridinone* (**2c**). First 4.6 g 3-benzyoxy-2-methyl-4-pyrone (21.3 mmol) and 6.9 g *p*-phenylenediamine (63.9 mmol) were added in a mixture solvent of 40 mL EtOH and 20 mL water, then 0.5 g NaOH was added and stirred at 90 °C for 8 h. After cooling, 2 M HCl was added until the pH = 1 and the solvent was evaporated. The residue was washed with acetone and dissolved in 20 mL water. The obtained solution was basified with 10 M NaOH until pH = 12 and extracted with dichloromethane (5 × 30 mL). The organic phase was evaporated under reduced pressure and the residue was dissolved in 10 mL ethanol. Then 200 mL diethyl ether was added to afford the light yellow rude product, which was purified by chromatography on a silica gel column with a mixture of methanol: chloroform = 1:20 as eluent to afford a white powder (6.25 g, 69%). UV-vis (CH~3~OH): λ~max~ = 207, 250, 279 nm. FT-IR(KBr): ν = 3434, 3347 (N-H), 3232 (C-H), 2961 (C-H), 1619 (C=O), 1567, 1511, 1479, 1358, 1281, 1162, 953, 843, 764, 703 cm^−1^. ^1^H-NMR (300 MHz, CDCl~3~): δ = 7.44 (d, *J* = 6.8 Hz, 2H, 7.28--7.36 (m, 3H), 7.23 (d, *J* = 6.8 Hz, 1H), 6.94 (d, *J* = 8.5 Hz, 2H), 6.66 (d, *J* = 8.5 Hz, 2H), 6.41 (d, *J* = 6.8 Hz, 1H), 5.24 (s, 2H, *CH*~2~Ph), 1.82 (t, *J* = 7.5 Hz, 3H, C*H*~3~). MS (ESI) *m*/*z* (%) = 307 (100) \[M + H\]^+^. C~19~H~18~O~2~N~2~ (306): calcd. C 74.51, H 5.88, N 9.15; found: C 74.32, H 5.92, N 9.13.

*Synthesis of N,N′-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)phenyl)malonamide* (**3c**). First 1.6 g *N*-(4-aminophenyl)-3-benzyloxy-2-methyl-4-pyridinone **2c** was stirred at 0 °C under N~2~. Then 300 μL malonyl dichloride was diluted with 20 mL dichloromethane and then dropwise added slowly and consecutively keeping the temperature at 0 °C for 8 h. The mixture was purified by chromatography on a silica-gel column with the methanol:chloroform = 1:8 as eluent, and the pure product was faint yellow powder (1.5 g, 86%). UV-vis (CH~3~OH): λ~max~ = 208, 251, 281 nm. FT-IR (KBr): ν = 3247, 3189, 3056, 2926, 1697, 1625, 1546, 1508, 1409, 1341, 1287, 1172, 1004, 988, 834, 751, 701 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ = 7.64 (d, *J* = 8.5 Hz, 4H), 7.22--7.40 (m, 2H), 7.03 (d, *J* = 8.5 Hz, 4H), 6.66 (d, *J* = 7.5 Hz, 4H), 6.42 (d, *J* = 7.5 Hz, 2H), 5.08 (s, 4H, *CH*~2~Ph), 3.45 (s, 2H, COC*H*~2~CO), 1.71 (t, 6H, C*H*~3~) ppm. MS (ESI) *m*/*z* (%) = 681 (100) \[M + H\]^+^. C~41~H~36~O~6~N~4~ (680): calcd. C 72.35, H 5.29, N 8.24; found: C 72.24, H 5.35, N 8.20.

*Synthesis of N,N′-bis(4-(3-hydroxy-2-methyl-4-pyridinone)phenyl)malonamide* (**4c**). First 50 mg 10% Pd/C was added in a solution of *N,N′*-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)phenyl)malonamide **3c** (0.23 g, 3.38 mmol) in methanol (50 mL), then the mixture was stirred under H~2~ (1 atm) for 4 h at room temperature. After filtration, the solvent was evaporated under reduced pressure and the crude product was obtained as the white powder, which was recrystallized from methanol/diethyl ether (0.15 g, 90%). UV-vis (CH~3~OH): λ~max~ = 209, 251, 292 nm. FT-IR (KBr): ν = 3245 (N-H), 3121, 3063, 2928 (C-H), 1693 (HNC=O), 1626(PyC=O), 1605, 1538, 1505, 1411, 1297, 1243, 1116, 1041, 834 cm^−1^. ^1^H-NMR (600 MHz, CD~3~OD): δ = 7.87 (d, *J* = 7.8 Hz, 4H), 7.64 (d, *J* = 7.2 Hz, 2H), 7.38 (d, *J* = 8.5 Hz, 4H), 6.53 (d, *J* = 7.2 Hz, 2H), 3.63 (s, 2H, COC*H~2~*CO), 2.15 (s, 6H, C*H*~3~) ppm. ^13^C-NMR (150 MHz, CD~3~OD): δ = 165.70, 161.32, 143.03, 139.64, 137.69, 138.63, 136.65, 125.81, 119.98, 109.70, 29.39, 12.41 ppm. MS (ESI) *m*/*z* (%) = 523 (100) \[M + Na\]^+^. C~27~H~24~O~6~N~4~ (500): calcd. C 64.80; H 4.80, N 11.20; found: C 64.47, H 4.96, N 10.96.

*Synthesis of (3′-hydroxypropyl)-3-benzyloxy-2-methyl-4-pyridinone* (**2d**). First 3 g 3-benzyoxy-2-methyl-4-pyrone (13.9 mmol), 3.5 mL 1,3-propanol amine (45.8 mmol) and 0.5 g NaOH were added in a EtOH--water mixture (20/15) mL, and then stirred at 70 °C for 6 h. After cooling, 2 M HCl was added until the pH = 1 and the reaction solution was evaporated under vacuum. The residue was washed with acetone and dissolved in 20 mL water. The obtained solution was basified with 10 M NaOH until pH = 10 and extracted with dichloromethane (5 × 30 mL). The organic phase was evaporated and obtained the snow white powder (2.9 g, 75%). UV-vis (CH~3~OH): λ~max~ = 216, 274 nm. FT-IR (KBr): ν = 3336, 1632, 1522, 1494, 1419, 1352, 1263, 1159, 1157, 1084, 1035, 960, 842, 754, 706 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ = 7.62 (d, *J* = 7.4 Hz, 1H), 7.32--7.46 (5H, m), 6.46 (d, *J* = 7.4 Hz, 1H), 5.06 (s, 2H, *CH*~2~Ph), 4.13 (t, *J* = 7.1 Hz, 2H, HOC*H*~2~CH~2~), 4.03 (t, *J* = 7.1 Hz, 2H, HOCH~2~CH~2~C*H*~2~), 2.13 (s, 3H, C*H~3~*), 2.00 (t, *J* = 6.2 Hz, 2H, HOCH~2~C*H*~2~CH~2~) ppm. MS (APCI) *m*/*z* (%) = 274 (100) \[M + H\]^+^. C~16~H~19~O~3~N (273): calcd. C 70.33,H 6.96, N 5.13; found: C 70.08, H 6.78, N 5.26.

*Synthesis of N,N′-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)hydroxypropyl)malonicester* (**3d**). First 0.5 g (3′-hydroxypropyl)-3-benzyloxy-2-methyl-4-pyridinone (1.83 mmol) and 2 mL triethylamine were added in 50 mL dichloromethane, then mixture was stirred at 0 °C under N~2~. Then 100 μL malonyl dichloride was diluted with 20 mL dichloromethane and then dropwise added slowly and consecutively keeping the temperature at 0 °C for 6 h. The mixture was purified by chromatography on a silica-gel column with the methanol:chloroform =1:8 as eluent, and the pure product was faint yellow oil (0.2 g, 37%). UV-vis (CH~3~OH): λ~max~ = 218, 274 nm. FT-IR (KBr): ν = 2925, 1742, 1647, 1494, 1384, 1263, 1159, 1083, 1035, 842, 753, 706 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ = 7.18--7.36 (m, 12 H), 6.35 (d, *J* = 7.4 Hz, 2H), 5.08 (s, 4 H, *CH*~2~Ph), 4.06 (d, *J* = 4.5 Hz, 4H, OC*H*~2~CH~2~CH~2~), 3.83 (t, *J* = 6.6 Hz, 2H, OCH~2~CH~2~C*H*~2~), 3.36 (s, 2H, COC*H*~2~CO), 2.02 (s, 6H, C*H*~3~), 1.85--1.95 (m, 4H, OCH~2~C*H*~2~CH~2~) ppm. MS (APCI) *m*/*z* (%) = 308 (100) \[M + 2 H\]^+^. C~35~H~38~O~8~N~2~ (614): calcd. C 68.40, H 6.19, N 4.55; found: C 68.28, H 6.42, N 4.37.

*Synthesis of N,N′-Bis(4-(3-hydroxy-2-methyl-4-pyridinone)-hydroxyethyl)-malonic ester* (**4d**). First 40 mg 10% Pd/C was added in a solution of *N,N′*-bis(4-(3-hydroxy-2-methyl-4-pyridinone)hydroxyethyl)-malonic ester (0.22 g, 0.34 mmol) in methanol (50 mL), then the mixture was stirred under H~2~ (1 atm) for 6 h at room temperature. After filtration, the solvent was evaporated under reduced pressure and the crude product was obtained as the white powder (0.11 g, 71%). UV-vis (CH~3~OH): λ~max~ = 284 nm. FT-IR (KBr) ν/cm^−1^: 3399, 2965, 2426, 1731, 1632, 1508, 1383, 1255, 1162, 1032, 827. ^1^H-NMR (600 MHz, CD~3~OD): δ = 7.99 (d, *J* = 7.2 Hz, 2H), 6.88 (d, *J* = 7.2 Hz, 2H), 4.39 (t, *J* = 4.5 Hz, 4H, OC*H*~2~CH~2~CH~2~), 4.22 (t, *J* = 6.6 Hz, 4H, OCH~2~CH~2~C*H*~2~), 3.67 (s, 2H, COC*H~2~*CO), 2.17 (s, 6H, CH~3~), 2.00--2.20 (m, 4H, OCH~2~C*H~2~*CH~2~); MS (APCI) *m*/*z* (%) = 435 (100) \[M + H\]^+^. C~21~H~26~O~8~N~2~ (434): calcd. C 58.06, H 5.99, N 6.45; found: C 58.13, H 6.07, N 6.21.

*Synthesis of (3′-Hydroxyethyl)-3-benzyloxy-2-methyl-4-pyridinone* (**2e**). First 4.3 g 3-benzyoxy-2-methyl-4-pyrone (19.9 mmol), 3.3 mL 2-aminoethanol (49.3 mmol) and 0.5 g NaOH were added in a mixture solvent of 20 mL EtOH and 15 mL water mixture, and then stirred at 70 °C for 6 h. After cooling, 2 M HCl was added until the pH = 1 and the reaction solution was evaporated under vacuum. The residue was washed with acetone and dissolved in 20 mL water. The obtained solution was basified with 10 M NaOH until pH = 10 and extracted with dichloromethane (5 × 30 mL). The organic phase was evaporated and obtained the snow white powder (4.6 g, 89%). UV-vis (CH~3~OH): λ~max~ = 215, 270 nm. FT-IR (KBr): ν = 3335, 1636 (C=O), 1523, 1492, 1342, 1295, 1271, 1157, 1079, 1075, 1032, 969, 831, 768, 708 cm^−1^. ^1^H-NMR (300 MHz, CD~3~OD): δ = 8.32 (1 H, d, *J* = 7.2 Hz), 7.36--7.44 (m, 5H), 7.23 (d, *J* = 7.2 Hz, 1H), 5.17 (s, 2H, C*H*~2~Ph), 4.47 (t, *J* = 7.5 Hz, 2H, HO*CH~2~*CH~2~), 3.89 (t, *J* = 7.5 Hz, 2H, HOCH~2~C*H*~2~), 2.51 (s, 3H, C*H*~3~) ppm. MS (APCI) *m*/*z* (%)= 260 (100) \[M + H\]^+^. C~15~H~17~O~3~N (259): calcd. C 69.50, H 6.56, N 5.41; found: C 69.84, H 6.72, N 5.38.

*Synthesis of N,N′-bis(4-(3-benzyloxy-2-methyl-4-pyridinone)-Hydroxyethyl)-malonic ester* (**3e**). First 0.5 g (3′-hydroxyethyl)-3-benzyloxy-2-methyl-4-pyridinone (1.9 mmol) and 2 mL triethylamine were added in 50 mL dichloromethane, then mixture was stirred at 0 °C under N~2~. Then 100 μL malonyl dichloride was diluted with 20 mL dichloromethane and then dropwise added slowly and consecutively keeping the temperature at 0 °C for 6 h. The mixture was purified by chromatography on a silica-gel column with the methanol: chloroform=1:8 as eluent, and the pure product was faint yellow oil (0.12 g, 35%). UV/vis (CH~3~OH): λ~max~ *=* 220, 273 nm. FT-IR (KBr): ν = 2921, 2851, 1748, 1625, 1561, 1512, 1251, 1230, 1108, 1064, 825, 737, 701 cm^−1^. ^1^H-NMR (400 MHz, CD~3~OD): δ = 8.32 (d, *J* = 7.2 Hz, 2H), 7.36--7.44 (m, 10H), 7.26 (d, *J* = 7.2 Hz, 2H), 5.17 (s, 4H, C*H*~2~Ph), 4.47 (t, *J* = 7.8 Hz, 2H, OC*H*~2~CH~2~), 3.89 (t, *J* = 7.8 Hz, 2H, OCH~2~C*H*~2~), 3.69 (s, 2H, COC*H*~2~CO), 2.51(s, 3H, C*H~3~*). MS (APCI) *m*/*z* (%) = 587 (100) \[M + H\]^+^. C~33~H~34~O~8~N~2~ (586): calcd. C 67.58,; H 5.80, N 4.78; found: C 67.66, H 6.01, N 4.64.

*Synthesis of N,N′-Bis(4-(3-hydroxy-2-methyl-4-pyridinone)-hydroxyethyl)-malonic ester* (**4e**). First 40 mg 10% Pd/C was added in a solution of *N*,*N′*-bis(4-(3-hydroxy-2-methyl-4-pyridinone)-hydroxyethyl)-malonic ester (0.19 g, 0.34 mmol) in methanol (50 mL), then the mixture was stirred under H~2~ (1 atm) for 6 h at room temperature. After filtration, the solvent was evaporated under reduced pressure and the crude product was obtained as the white powder, which was recrystallized from methanol/diethyl ether (0.10 g, 76%). UV-vis (CH~3~OH) λ~max~ = 281 nm. FT-IR (KBr): ν = 3367, 2963, 1736, 1628, 1567, 1508, 1460, 1384, 1352, 1251, 1150, 1110, 1026, 831, 599 cm^−1^. ^1^H-NMR (600 MHz, CD~3~OD): δ = 8.31 (d, *J* = 7.2 Hz, 2H), 7.25 (d, *J* = 7.2 Hz, 2H), 4.38 (t, *J* = 7.8 Hz, 2H, OC*H*~2~CH~2~), 3.91 (t, *J* = 7.8 Hz, 2H, OCH~2~C*H*~2~), 3.67 (s, 2H, CO*CH~2~*CO), 2.49 (s, 3H, CH~3~). MS (APCI) *m*/*z* (%) = 407 (100) \[M + H\]^+^. C~19~H~22~O~8~N~2~ (406): calcd. C 56.16, H 5.42, N 6.90; found: C 56.32, H 5.63, N 7.02.

3.3. Metal Complexation Solutions {#sec3dot3-molecules-21-00299}
---------------------------------

In all the complexation studies in aqueous solution, the water was distilled three times and the atmospheric CO~2~ was excluded from the system with a purging steam of N~2~ under 80 °C. The UO~2~(NO~3~)~2~·6H~2~O is analytical grade, the buffered solution were NaAc/HAc (pH = 5.5) and Tris-HCl (pH = 7.4, 9.0). All the ligands were synthesized and dissolved into the water, except the solvent of the ligand **4c** was DMSO:H~2~O = 1:9 to ensure all the ligands was dissolved. The ligands concentration (C~L~) was 2.0 × 10^−3^ mol/L and the UO~2~^2+^ (C~M~) concentration was 2.0 × 10^−3^ mol/L, then added the solutions into the 10 mL comparison tubes by different volume, the total concentration (C~L~ + C~M~) was 2.0 × 10^−3^ mol/L for all complexation samples.

4. Conclusions {#sec4-molecules-21-00299}
==============

In summary, five new ligands of bis(3-hydroxy-4-pyridinone) tetradentate ligands were synthesized and characterized. The stability constants determined in this study provide evidence for the extremely high affinities of the ligands for UO~2~^2+^ complexes. The evident difference in logK~cond~, compared with the similar structural ligands, emphasized the superior affinity for UO~2~^2+^ of the **4b** ligand. At pH 7.4, the **4b** ligand shows a high constant of 22.7, confirming this compound as an effective chelator for UO~2~^2+^.
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![Synthesis for the ligands **4a**--**e**. *Reagents and conditions*: (i) BnBr, CH~3~OH, 75 °C, reflux 6 h; (ii) EtOH/H~2~O, NaOH, reflux 3 h, 10 M HCl, until pH = 1, 10 M NaOH, pH = 11; (iii) CH~2~(COCl)~2~, dried CH~2~Cl~2~, 0 °C, 8 h; (iv) H~2~, Pd/C, CH~3~OH, 4 h.](molecules-21-00299-g003){#molecules-21-00299-f003}

![The ^1^H-NMR spectra of **2a** (CD~3~OD), **3a** (CD~3~OD) and **4a** (DMSO-*d*~6~).](molecules-21-00299-g001){#molecules-21-00299-f001}

![UV-vis absorption spectra of the various metal-to-ligand molar ratios for the UO~2~^2+^-Ligand **4a**--**e** system at pH 7.4: C = 4.00 × 10^−4^ M, T = 25 °C, I = 0.1 M KNO~3~: (**a**) The spectrophotometric absorption curves of the UO~2~^2+^, ligand **4a** and UO~2~^2+^-ligand **4a**; (**b**) UO~2~^2+^-Ligand **4a** system; (**c**) UO~2~^2+^-Ligand **4b** system; (**d**) UO~2~^2+^-Ligand **4c** system; (**e**) UO~2~^2+^-Ligand **4d** system; (**f**) UO~2~^2+^-Ligand **4e** system. All illustrations were obtained from the wavelength of 320 nm.](molecules-21-00299-g002){#molecules-21-00299-f002}
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###### 

Summary of the logK~cond~ of ligand-UO~2~^2+^ (pH = 7.4 ± 0.1).

  L        logK~cond~U-L/(pH = 7.4)
  -------- --------------------------
  **4a**   21.7
  **4b**   22.7
  **4c**   18.6
  **4d**   21.4
  **4e**   22.2
